Buy the ProPeptide Tirzepatide 40mg vial in Dubai. Lyophilized vial format. Specified at ≥99% purity. Dual GLP-1 / GIP receptor agonist described in the SURPASS and SURMOUNT clinical research programs published in The New England Journal of Medicine and The Lancet. Same-day Dubai delivery.
- ≥99% Purity
- ProPeptide Brand Standard
- Same-Day Delivery
- Dubai
- Lyophilized Vial
- Research Format
- Cold-Chain Shipped
- +2 to +8°C
- 1x ProPeptide research vial (lyophilized powder)
- Cold-chain insulated packaging
Tirzepatide 40mg Vial
In stock · UAE delivery: AED 50 below AED 1,000; free from AED 1,000
Specified ≥99% ProPeptide Brand Standard
- Unit
- AED 600 / vial
- Per mg
- AED 15
- Total
- AED 600
Ships from Dubai
What Is Tirzepatide?
Tirzepatide (LY-3298176) is a dual receptor agonist peptide that binds the GLP-1 (glucagon-like peptide 1) receptor and the GIP (glucose-dependent insulinotropic polypeptide) receptor. The combined dual-receptor binding profile is the basis for the compound's metabolic effects described in the published literature.
In the SURPASS program (Phase 3, type 2 diabetes) and the SURMOUNT program (Phase 3, weight management), tirzepatide reported substantial reductions in HbA1c and body weight. SURMOUNT-1 reported approximately 22.5% body weight reduction at 72 weeks at the highest study dose. The compound is approved for human-use indications under licensed pharmaceutical brand names in multiple regulated markets.
The 40mg vial is the lyophilized research format. Reconstitute with bacteriostatic water using sterile technique. The ProPeptide vial is the research-grade lyophilized peptide and is separate from any licensed pharmaceutical product.
Why Buy Tirzepatide 40mg from ProPeptide?
Sealed lyophilized vial.
Each vial is lyophilized in a controlled environment and sealed with a crimp cap. Reconstitute with bacteriostatic water using sterile technique. Once reconstituted, store refrigerated and protect from light.
Same-day Dubai delivery.
Orders placed before 4 PM ship same day within Dubai. Outside Dubai, order before 12 PM (noon) for next-day delivery. Orders placed on Saturday will be delivered on Monday, and Sunday delivery is not available outside Dubai. Delivery costs AED 50 below AED 1,000 and is free from AED 1,000. Cold-chain insulated packaging maintains the +2 to +8°C range from our facility to your door.
Product-specific documentation.
Specifications and documentation are kept product-specific and current.
Technical Specifications
| Manufacturer | ProPeptide |
|---|---|
| Compound | Tirzepatide (LY-3298176) |
| CAS Number | 2023788-19-2 |
| Quantity | 40mg per vial |
| Format | Lyophilized powder, sealed glass vial |
| Purity | Specified ≥99% |
| Molecular Weight | ~4,800 Da |
| Sequence | 39 amino acid synthetic peptide with C20 fatty diacid side chain |
| Storage | +2 to +8°C lyophilized. Reconstituted: +2 to +8°C, protect from light, do not freeze. |
How Tirzepatide Works: Dual Receptor Mechanism
Tirzepatide is the first dual GLP-1 / GIP receptor agonist studied in published Phase 3 metabolic research.
GLP-1 (glucagon-like peptide 1) receptor
Promotes satiety signaling, slows gastric emptying, and stimulates glucose-dependent insulin secretion. The same pathway targeted by semaglutide as a single receptor agonist.
GIP (glucose-dependent insulinotropic polypeptide) receptor
Enhances post-prandial insulin response, has direct effects on adipose tissue, and acts synergistically with GLP-1 to amplify metabolic signaling. Tirzepatide's distinguishing target compared with single-agonist GLP-1 compounds.
Synergy
Activating both receptors at once is reported in the published research to drive larger reductions in HbA1c and body weight than single GLP-1 receptor agonists, while preserving glucose-dependent insulin secretion.
Tirzepatide vs Retatrutide vs Semaglutide: Research Comparison
| Tirzepatide | Retatrutide | Semaglutide | |
|---|---|---|---|
| Receptor Targets | GLP-1 + GIP | GLP-1 + GIP + Glucagon | GLP-1 only |
| Mechanism | Dual receptor agonist | Triple receptor agonist | Single receptor agonist |
| Max Weight Reduction (published) | 22.5% at 72 weeks (SURMOUNT-1) | 24.2% at 48 weeks (Phase 2) | 14.9% at 68 weeks (STEP 1) |
| Increases Energy Expenditure | No | Yes (glucagon) | No |
| Regulatory status (research literature) | Approved for human use under licensed brands | Investigational (Phase 3, TRIUMPH program) | Approved for human use under licensed brands |
| Format (at ProPeptide) | 40mg vial | Pens 10/20/30/40mg, vials 10/40mg | n/a |
Dosing Reference
Published clinical research uses a slow titration schedule. Reconstitute the 40mg vial with bacteriostatic water. The volume of bacteriostatic water you add determines the concentration per unit.
| Stage | Amount | Purpose |
|---|---|---|
| 1–4 | 2.5mg / week | Initial tolerance assessment |
| 5–8 | 5mg / week | Gradual escalation |
| 9–12 | 7.5mg / week | Continued escalation |
| 13–16 | 10mg / week | Continued escalation |
| 17+ | 12.5–15mg / week | Target research amount |
This information is derived from published research and is provided for reference only. ProPeptide does not provide research protocols and does not give dosing advice. Always consult a qualified healthcare professional.
To try other water volumes or vial strengths, use the reconstitution calculator.
For research purposes only. Not for human consumption.
Frequently Asked Questions
Where can I buy Tirzepatide vials in Dubai?
ProPeptide ships the Tirzepatide 40mg vial directly from Dubai. Same-day delivery is available on orders placed before 4 PM. Outside Dubai, Saturday orders are delivered on Monday. Delivery costs AED 50 below AED 1,000 and is free from AED 1,000.
How does Tirzepatide compare to Retatrutide?
Tirzepatide is a dual receptor agonist (GLP-1 + GIP). Retatrutide is a triple receptor agonist (GLP-1 + GIP + glucagon). These results come from separate, non-head-to-head trials. Tirzepatide's SURMOUNT-1 reported 22.5% reduction at 72 weeks. Retatrutide's published Phase 2 trial reported 24.2% at 48 weeks at the highest dose, while Lilly's Phase 3 TRIUMPH-1 topline results reported 28.3% at 80 weeks at 12mg, pending full peer-reviewed publication.
Is this the same as the licensed pharmaceutical version of tirzepatide?
No. Tirzepatide is approved under licensed pharmaceutical brand names in regulated markets. ProPeptide does not sell licensed pharmaceuticals. The ProPeptide vial is the research-grade lyophilized peptide for laboratory studies and is separate from any licensed pharmaceutical product.
What is the Tirzepatide vial price at ProPeptide?
The 40mg Tirzepatide vial is AED 600.
How should I store the Tirzepatide vial?
Lyophilized vial: +2 to +8°C. Once reconstituted: +2 to +8°C, protect from light, do not freeze. The vial ships in cold-chain insulated packaging and should be refrigerated immediately on receipt.